ABSTRACT:
Background: Perindopril is an an angiotensin-converting enzyme (ACE) inhibitor, newly introduced into Iraqi market and widely prescribed for hypertension and cardiovascular disorders. Cough as a usual side effect associated with ACE inhibitors vary based on ethnic group. The present study thought to Determine the prevalence perindopril-associated cough as new introducers in Iraqi market. Methods: This cross sectional study was conducted in adult (aged>18 ) hypertensive patients visiting private clinics in Duhok city, who had been treated by perindopril for at least two weeks. A questionnaire was handed to individuals to collect demographic data, duration and indication of perindopril use, presence of cough, time of onset of cough, and comorbidities. Results: The results revealed that 61% (n=51) of participants accepted the perindopril without cough, while 39% (n=33) demonstrated non-tolerable cough. The prevalence of tolerability in male (76.7%) and female (83.3) patients were higher compared to non-tolerable participants. Patients aged =50 years demonstrated higher cough tolerability (72%). However, >50 years old participants demonstrated lower tolerability rates (55.9%), with 44.1% demonstrated non-tolerable cough. Conclusions: Perindopril has induced a higher non-tolerable cough in younger age group regardless of gender differences or residency status.
Cite this article:
Abdulaziz Mohsin Brifkani. Prevalence of Cough among patients on Perindopril in Duhok City. Research Journal Pharmacy and Technology. 2026;19(3):1199-2. doi: 10.52711/0974-360X.2026.00171
Cite(Electronic):
Abdulaziz Mohsin Brifkani. Prevalence of Cough among patients on Perindopril in Duhok City. Research Journal Pharmacy and Technology. 2026;19(3):1199-2. doi: 10.52711/0974-360X.2026.00171 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-3-32
REFERENCES:
1. Abbood A. Layka R. Weight and content uniformity Study of captopril half-tablets. Research Journal of Pharmacy and Technology. 2017; 10(6): 1621-6. https://doi.org/10.5958/0974-360X.2017.00285.2.
2. Siridevi MP. Hemant KT. Srinivasa RY. Varaprasad RK. Simultaneous spectrophotometric estimation of amlodipine besylate and Perindopril Erbumine in tablet formulation. Research Journal of Pharmacy and Technology. 2019; 12(12): 6101-6. https://doi.org/10.5958/0974-360X.2019.01060.6.
3. Jayarao YR. Deborah D. Ambedkar T. Babu SM. Formulation and evaluation of fast dissolving oral films of perindopril. Research Journal of Pharmaceutical Dosage Forms and Technology. 2014; 6(2): 71. https://doi.org/10.5958/0975-4377.
4. Jaiswal H. Ansari VA. Pandit JN. Ahsan F. Pulsatile drug delivery system: an overview with special emphasis on losartan and captopril. Research Journal of Pharmacy and Technology. 2019; 12(7): 3175-88. https://doi.org/10.5958/0974-360X.2019.00535.3.
5. Meher B. Satapathy T. Parida J. Maharana A. Comparative Study between ACE Inhibitors and ARB in hypertensive Patients. Research Journal of Pharmacology and Pharmacodynamics. 2012; 4(5): 263-6. https://doi.org/10.5958 2321-5836.
6. Al-Saad HN. Kubba AA. Evaluation of New Thiosemcarbazides Derived from Captopril as Angiotensin-Converting Enzyme Inhibitors with Docking Study, and Predicted-ADMET Analysis. Research Journal of Pharmacy and Technology. 2020; 13(6): 2733-41. https://doi.org/10.5958/0974-360X.2020.00486.2.
7. Mahmoudpour SH. Leusink M. Putten LV. Terreehorst I. Asselbergs FW. De Boer A. Maitland-Van Der Zee AH. Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis. Pharmacogenomics. 2013; 14(3): 249-60. https://doi.org/10.2217/pgs.12.206.
8. Singh PK. Chen ZL. Ghosh D. Strickland S. Norris EH. Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients. Neurobiology of disease. 2020; 139: 104833. https://doi.org/10.1016/j.nbd.2020.104833.
9. Lowery EM. Brubaker AL. Kuhlmann E. Kovacs EJ. The aging lung. Clinical interventions in aging. 2013 Nov 6: 1489-96. https://doi.org/10.2147/CIA.S51152.
10. BBrandenberger C. Mühlfeld C. Mechanisms of lung aging. Cell and Tissue Research. 2017; 367(3): 469-80. https://doi.org/10.1007/s00441-016-2511-x.
11. Ramsdale E. Mohamed M. Yu V. Otto E. Juba K. Awad H. Moorthi K. Plumb S. Patil A. Vogelzang N. Dib E. Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment. The oncologist. 2022 Jul 1; 27(7): e580-8. https://doi.org/10.1093/oncolo/oyac053.
12. Dicpinigaitis PV. Rauf K. The influence of gender on cough reflex sensitivity. Chest. 1998 May 1; 113(5): 1319-21. https://doi.org/10.1378/chest.113.5.1319.
13. Kavalcikova-Bogdanova N. Kovacikova L. Buday T. Biringer K. Sivakova J.. Calkovsky V. Antosova M. Plevkova J. Sensitivity of airway cough-related afferents is influenced by female sex hormones. Respiratory physiology & neurobiology. 2018 Nov 1; 257: 12-7. https://doi.org/10.1016/j.resp.2018.01.006.
14. Kavalcikova-Bogdanova N. Buday T. Plevkova J. Song WJ. Chronic cough as a female gender issue. Respiratory Contagion. 2016 Jan 9: 69-78. https://doi.org/10.1007/5584_2015_182.
15. Ding H. Shi C. Xu X. Yu L. Drug-induced chronic cough and the possible mechanism of action. Annals of Palliative Medicine. 2020 Sep; 9(5): 3562570-3570. https://doi.org/10.21037/apm-20-819.
16. El-Hashim AZ. Amine SA. The role of substance P and bradykinin in the cough reflex and bronchoconstriction in guinea-pigs. European journal of pharmacology. 2005 Apr 18; 513(1-2): 125-33. https://doi.org/10.1016/j.ejphar.2005.02.007.
17. Desalu OO. Salami AK. Fawibe AE. Prevalence of cough among adults in an urban community in Nigeria. West African journal of medicine. 2011; 30(5): 337-41. https://doi.org/10.4314/wajm.v30i5.
18. Rodriguez A. Brickley E. Rodrigues L. Normansell RA. Barreto M. Cooper PJ. Urbanisation and asthma in low-income and middle-income countries: a systematic review of the urban–rural differences in asthma prevalence. Thorax. 2019 Nov 1; 74(11): 1020-30. https://doi.org/10.1136/thoraxjnl-2018-211793.
19. Nwia SM. Leite AP. Li XC. Zhuo JL. Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases. Frontiers in Cardiovascular Medicine. 2023 Jun 19; 10: 1198090. https://doi.org/10.3389/fcvm.2023.1198090.
20. Rowan MP. Berg KA. Roberts JL. Hargreaves KM. Clarke WP. Activation of estrogen receptor α enhances bradykinin signaling in peripheral sensory neurons of female rats. The Journal of Pharmacology and Experimental Therapeutics. 2014 Jun 1; 349(3): 526-32. https://doi.org/10.1124/jpet.114.212977.
21. Rowan MP. Berg KA. Milam SB. Jeske NA. Roberts JL. Hargreaves KM. Clarke WP. 17β-Estradiol rapidly enhances bradykinin signaling in primary sensory neurons in vitro and in vivo. The Journal of pharmacology and experimental therapeutics. 2010 Oct 1; 335(1): 190-6. https://doi.org/10.1124/jpet.110.167445.
22. Packard KA. Wurdeman RL. Arouni AJ. ACE Inhibitor—Induced Bronchial Reactivity in Patients with Respiratory Dysfunction. Annals of Pharmacotherapy. 2002 Jun; 36(6): 1058-67. https://doi.org/10.1345/aph.1A332.
23. Regitz-Zagrosek V. Sex and gender differences in heart failure. International journal of heart failure. 2020 Apr 13; 2(3): 157. https://doi.org/10.36628/ijhf.2020.0004.
24. Elliott WJ. Bistrika EA. Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation. Expert opinion on drug safety. 2018 Feb 1; 17(2): 207-16. https://doi.org/10.1080/14740338.2018.1397129.